**PORTFOLIO ALLOCATION DECISION**

**INVESTMENT PHILOSOPHY:**
For this portfolio, we will adhere to a blend of consensus-driven and quality investing principles, leveraging insights from our expert panel. Our core principles are:
1. **Consensus and Conviction**: Prioritize stocks with the highest consensus among experts, indicating strong collective conviction.
2. **Quality and Financial Health**: Focus on companies with robust financial metrics and sustainable competitive advantages.
3. **Diversification and Risk Management**: Ensure a balanced portfolio to manage risk through diversification across sectors and investment styles.

**KEY ALLOCATION DRIVERS:**
1. **Expert Consensus**: Stocks with higher consensus rates are prioritized, reflecting collective expert confidence.
2. **Quality Metrics**: Emphasis on financial strength, competitive moats, and growth potential.
3. **Sector Diversification**: Balance exposure across different sectors to mitigate risk and capture diverse growth opportunities.

**FINAL PORTFOLIO ALLOCATION:**

| Rank | Stock | Weight(%) | Supporting Experts | Key Investment Thesis | Risk Level |
|------|-------|-----------|-------------------|----------------------|------------|
| 1    | MSFT  | 15.0      | BenjaminGraham, WarrenBuffett | High ROIC, strong moat, and growth potential | Medium |
| 2    | NVDA  | 12.5      | BenjaminGraham, WarrenBuffett | Leader in AI and graphics, strong growth | Medium |
| 3    | AVGO  | 12.5      | JosephPiotroski, WarrenBuffett | Strong financials, diversified tech exposure | Medium |
| 4    | VRTX  | 12.5      | EdwardAltman, WarrenBuffett | Strong pipeline, financial health | Medium |
| 5    | META  | 10.0      | JoelGreenblatt, WarrenBuffett | Strong user base, growth in digital advertising | Medium |
| 6    | MU    | 10.0      | BenjaminGraham, JoelGreenblatt | Attractive valuation, memory market leader | High |
| 7    | REGN  | 10.0      | BenjaminGraham, EdwardAltman | Strong drug pipeline, financial stability | Medium |
| 8    | TXN   | 7.5       | BenjaminGraham, EdwardAltman | Strong financials, diversified semiconductor exposure | Medium |
| 9    | ROE   | 5.0       | BenjaminGraham, WarrenBuffett | Consistent returns, financial strength | Medium |
| 10   | QCOM  | 5.0       | BenjaminGraham, JoelGreenblatt | Strong position in 5G, attractive valuation | Medium |

**PORTFOLIO CHARACTERISTICS:**
- Total Allocation: 100%
- Number of Holdings: 10 stocks  
- Top 5 Holdings: 62.5% of portfolio
- Sector Concentration: Balanced exposure across technology, healthcare, and consumer sectors

**RISK MANAGEMENT:**
- Key portfolio risks: Overexposure to technology sector, market volatility
- Monitoring metrics: Regular review of financial performance, market conditions, and sector trends
- Rebalancing triggers: Significant changes in consensus, financial health deterioration, or sector overconcentration

In constructing this portfolio, we have prioritized stocks with strong expert consensus and robust financial metrics, ensuring a diversified and balanced approach to maximize returns while managing risk. This strategy aligns with our past successful decisions, focusing on quality and consensus-driven investments.